Contract research organization

Last updated

In the life sciences, a contract research organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biological assay development, commercialization, clinical development, clinical trials management, pharmacovigilance, outcomes research, and real world evidence. [1]

Contents

CROs are designed to reduce costs for companies developing new medicines and drugs in niche markets. They aim to simplify entry into drug markets, and simplify development, as the need for large pharmaceutical companies to do everything ‘in house’ is now redundant. CROs also support foundations, research institutions, and universities, in addition to governmental organizations (such as the NIH, EMA, etc.). [2]

Many CROs specifically provide clinical-study and clinical-trial support for drugs and/or medical devices. [3] [4] However, the sponsor of the trial retains responsibility for the quality of the CRO's work. [5] CROs range from large, international full-service organizations to small, niche specialty groups. CROs that specialize in clinical-trials services can offer their clients the expertise of moving a new drug or device from its conception to FDA/EMA marketing approval, [6] without the drug sponsor having to maintain a staff for these services. [7]

Organizations who have had success in working with a particular CRO in a particular context (e.g. therapeutic area) might be tempted or encouraged to expand their engagement with that CRO into other, unrelated areas; however, caution is required as CROs are always seeking to expand their experience and success in one area cannot reliably predict success in unrelated areas that might be new to the organization. [5]

Definition, regulatory aspects

The International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, a 2015 Swiss NGO of pharmaceutical companies and others, defined a contract research organization (CRO), specifically pertaining to clinical trials services as: [8] : 10  "A person or an organization (commercial, academic, or other) contracted by the sponsor to perform one or more of a sponsor's trial-related duties and functions."

It further details the sponsor's responsibilities in its good clinical practice guidelines: [8] : 22–23 

Guidance from the US FDA published in 2013 also speaks to the responsibility of the sponsor to oversee work of the CRO, including the circumstance where risk-based monitoring has been delegated to the CRO. [5] 2021 saw a major update to US FDA regulations related to providing the agency with information about CROs and how they "comply with FDA regulations". [5]

Market size and growth

As of 2013, there were over 1,100 CROs in the world, despite continued trends toward consolidation. Many CROs have been acquired while others have gone out of business. [9] The industry is fragmented, with the top 10 companies controlling 56% of the market in 2008 [10] and 55% in 2009. [11] In 2018 global CRO market stood at $38,396.4 mln. and is projected to reach $90,926.3 mln. by the end of 2026, exhibiting a CAGR of 11.4% in the forecast period. [12]

Top CROs by annual revenue

As of 2016, there was a 15.5% increase in R&D spending from 2015 to 2020. [13] The list of contract research organizations includes the following notable companies worldwide:

  1. Labcorp ($14.00B revenue in 2020) [14]
  2. IQVIA ($11.35B revenue in 2020) [15]
  3. PPD, Inc. ($4.68B revenue in 2020) [16]
  4. Syneos Health ($4.41B revenue in 2020) [17]
  5. Charles River Laboratories ($2.92B revenue in 2020) [18]
  6. ICON PLC ($2.79B revenue in 2020) [19]
  7. Parexel ($2.44B revenue in 2017)
  8. Wuxi Apptec ($1.01B revenue in 2017)
  9. Medpace ($0.92B revenue in 2020) [20]

See also

Related Research Articles

<span class="mw-page-title-main">Clinical trial</span> Phase of clinical research in medicine

Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments and known interventions that warrant further study and comparison. Clinical trials generate data on dosage, safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial—their approval does not mean the therapy is 'safe' or effective, only that the trial may be conducted.

<span class="mw-page-title-main">Biogen</span> Pharmaceutical company

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland.

An orphan drug is a pharmaceutical agent that is developed to treat certain rare medical conditions. An orphan drug would not be profitable to produce without government assistance, due to the small population of patients affected by the conditions. The conditions that orphan drugs are used to treat are referred to as orphan diseases. The assignment of orphan status to a disease and to drugs developed to treat it is a matter of public policy that depends on the legislation of the country.

<span class="mw-page-title-main">Pharmaceutical industry</span> Industry involved with discovery, development, production and marketing of drugs

The pharmaceutical industry is an industry involved in medicine that discovers, develops, produces, and markets pharmaceutical goods for use as drugs that function by being administered to patients using such medications with the goal of curing and/or preventing disease. Pharmaceutical companies may deal in "generic" medications and medical devices without the involvement of intellectual property, in "brand" materials is specifically tied to a given company's history, or in both within different contexts. The industry's has various subdivisions are all subject to a variety of laws and regulations that govern entire financial processes including the patenting, efficacy testing, safety evaluation, and marketing of these drugs. The global pharmaceuticals market produced treatments worth $1,228.45 billion in 2020, in total, and this showed a compound annual growth rate (CAGR) of 1.8% given the results of recent events.

<span class="mw-page-title-main">Labcorp Drug Development</span> Contract research organization

Labcorp Drug Development presently known as Fortrea is a contract research organization headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries. Formerly called Covance, the company is a spin-off from Labcorp, which employs more than 70,000 people worldwide.

<span class="mw-page-title-main">Amgen</span> American multinational biopharmaceutical company

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total.

Clinical monitoring is the oversight and administrative efforts that monitor a participant's health and efficacy of the treatment during a clinical trial. Both independent and government-run grant-funding agencies, such as the National Institutes of Health (NIH) and the World Health Organization (WHO), require data and safety monitoring protocols for Phase I and II clinical trials conforming to their standards.

In drug development and production, good clinical practice (GCP) is an international quality standard, which governments can then transpose into regulations for clinical trials involving human subjects. GCP follows the International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), and enforces tight guidelines on ethical aspects of clinical research.

<span class="mw-page-title-main">Drug development</span> Process of bringing a new pharmaceutical drug to the market

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes preclinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug. The entire process—from concept through preclinical testing in the laboratory to clinical trial development, including Phase I–III trials—to approved vaccine or drug typically takes more than a decade.

An electronic data capture (EDC) system is a computerized system designed for the collection of clinical data in electronic format for use mainly in human clinical trials. EDC replaces the traditional paper-based data collection methodology to streamline data collection and expedite the time to market for drugs and medical devices. EDC solutions are widely adopted by pharmaceutical companies and contract research organizations (CRO).

IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of US$49 billion as of August 2021. As of 2023, IQVIA was reported to be one of the world's largest contract research organizations (CRO).

Laboratory Corporation of America Holdings (Labcorp), headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.

A Site Management Organization (SMO) is an organization that provides clinical trial-related services to a contract research organization (CRO), a pharmaceutical company, a biotechnology company, a medical device company, or a clinical site. The site is usually a hospital or a similar health care institution that has adequate infrastructure and staff to meet the requirements of the clinical trial protocol. The scope of an SMO's responsibility is limited to the site and hence the eponymous title. Some of the responsibilities include:

<span class="mw-page-title-main">Wolfe Laboratories</span>

Wolfe Laboratories, Inc. (WLI) was a contract research organization (CRO) headquartered in Woburn, Massachusetts. It provided research and development services as well as GLP analytical services for products in late discovery phase through early clinical phases of drug development. It served clients in New England, the US and internationally. Laboratory operations took place in a large 21,000-square-foot (2,000 m2) facility.

Melior Discovery, Inc. is a private biopharmaceutical company based in Exton, Pennsylvania, USA.

<span class="mw-page-title-main">Phases of clinical research</span> Clinical trial stages using human subjects

The phases of clinical research are the stages in which scientists conduct experiments with a health intervention to obtain sufficient evidence for a process considered effective as a medical treatment. For drug development, the clinical phases start with testing for drug safety in a few human subjects, then expand to many study participants to determine if the treatment is effective. Clinical research is conducted on drug candidates, vaccine candidates, new medical devices, and new diagnostic assays.

An electronic trial master file (eTMF) is a trial master file in electronic format. It is a type of content management system for the pharmaceutical industry, providing a formalized means of organizing and storing documents, images, and other digital content for pharmaceutical clinical trials that may be required for compliance with government regulatory agencies. The term eTMF encompasses strategies, methods and tools used throughout the lifecycle of the clinical trial regulated content. An eTMF system consists of software and hardware that facilitates the management of regulated clinical trial content. Regulatory agencies have outlined the required components of eTMF systems that use electronic means to store the content of a clinical trial, requiring that they include: Digital content archiving, security and access control, change controls, audit trails, and system validation.

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

A Pharmaceutical Physician is a healthcare professional, usually a medical physician, who works in drug development. They work in biotechnology companies, Contract Research Organisations (CROs), Regulatory Authorities, and pharmaceutical companies.

<span class="mw-page-title-main">Syneos Health</span> Contract research organization

Syneos Health is an American company that provides contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina, the company specializes in helping other companies with late-stage clinical trials, but also provides commercial services to market health treatments.

References

  1. ↑ Nick Lucas (2021-04-09). "Contract Research Organizations: Key Partners In The Drug Development Journey". Forbes.com. Retrieved 2022-01-22.
  2. ↑ "The CRO Market", Association of Clinical Research Organizations.
  3. ↑ "The CRO Market" Archived 2013-07-03 at the Wayback Machine , Association of Clinical Research Organizations.
  4. ↑ "Contract Research Organization". Activa CRO.
  5. 1 2 3 4 Sather, Sandra; Lawyer, Jennifer (30 June 2022). "CRO Oversight Essentials". Clinical Leader (Guest column). Pennsylvania, United States: VertMarkets. Retrieved 30 July 2022.
  6. ↑ Fanelli, Alex (2017). "Contract Research Organizations (CRO)" . Retrieved 13 December 2017.
  7. ↑ "Bio-Definitions", Biotech Media. Archived 2009-01-01 at the Wayback Machine
  8. 1 2 E6(R2) Good Clinical Practice International Council on Harmonisation good clinical practice, 66 ppp, amended Nov 2016, accessed 30 Jan 2018
  9. ↑ "CRO Industry Could See More Consolidation, Experts Say" Archived 2013-09-26 at the Wayback Machine outsourcing-pharma.com, 2013-06-20 Retrieved 2013-09-24
  10. ↑ The Top 10 Contract Research Organizations -Positioning, performance and SWOT analyses bioportfolio.com, 5 February 2010
  11. ↑ "The CRO Market Outlook!publisher =globalbusinessinsights.com" (PDF). Archived from the original (PDF) on December 18, 2010. Retrieved February 5, 2013.
  12. ↑ "Contract Research Organizations (CRO) services market". fortunebusinessinsights.com. 2019-07-02. Retrieved 2020-05-20.
  13. ↑ Ed Miseta (11 February 2016). "Clinical Outsourcing Market To See Continued Growth Through 2020". www.clinicalleader.com.
  14. ↑ "Labcorp Announces 2020 Fourth Quarter and Full Year Results and Provides 2021 Guidance". Businesswire. 2021-02-11.
  15. ↑ "IQVIA Reports Fourth-Quarter and Full-Year 2020 Results, Raises Full-Year 2021 Guidance". Businesswire. 2021-02-10.
  16. ↑ "PPD Reports Fourth Quarter and Full Year 2020 Results". Businesswire. 2021-02-23.
  17. ↑ "Syneos Health Reports Fourth Quarter and Full Year 2020 Results". Globenewswire (Press release). 2021-02-18.
  18. ↑ "Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance". Businesswire. 2021-02-17.
  19. ↑ "ICON Reports Fourth Quarter and Full Year 2020 Results". Yahoo Finance. 2021-02-24.
  20. ↑ "Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2020 Results". Nasdaq. 2021-02-15.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.